Extensive experience in the pharmaceutical industry with focus on solid oral DF enables EMOVIAR to offer a consulting service in Drug Product Development and Manufacturing. Our clients benefit from our comprehensive and intergrated view on all related aspects of development, regulatory affairs, manufacturing and quality. We present a "straigth forward", conclusive solution rather than raising additional questions beyond the specified task.
Examples demonstrating our Consulting Service Approach:
Our definition of a superior Drug Product Design:
Sounds like a SWISS ARMY KNIFE?
Our widespread experience in development, RA, QC/QA & manufacturing enables us to offer a Development Strategy Review with the intention to identify potential pitfalls at the time of project initiation - rather than relying on trouble shooting capabilities after product filing and launch. GIVE US A TRY !
In regulated industries like pharma Trouble Shooting is a "nightmare". A problem needs to be solved under time pressure but actions still need to be compliant with GMP and filed product documentation. Based on focused but bias-free data analysis and a comprehensive understanding of the GMP- "does" and dont's" EMOVIAR is able to guide trouble shooting activities with meaningful analytical and technical Investigations.
In FDA 483 Root Cause Analysis is frequently critized as superficial and non comprehensive. Analytical skills and a widespread view on related disciplines enables EMOVIAR to conduct a meaningful root cause analysis whith a comprehensive and conclusive result.
A NICE Manufacturing Facility Design is not necessarily a GOOD design. Design qualification checks against URS are the rigth way to a BETTER design.
A Design Review conducted by EMOVIAR emphazies on Combining GMP and Productivity rather than dealing with its contradictions. The result will be regarded as innovative and OUTSTANDING.
Pharmaceutical Drug Product Manufacturing processes must be robust and validated to ensure a consistent and pre-defined quality of the drug product. This is documented in the filed drug product specification - finally THE link to the pivotal clinical trial formulation on which the drug product demonstrated its performance. Any change of the manufactruing of the drug product has to be treated carefully and is considered as major and complex exercise.
EMOVIAR is able to identify opportunities as well as GMP and regulatory consequnces of Process Optimisation and/or Digitalisation. Our service will provide a Change Control Road Map including economic impact with the overall goal to maintain a compliant pharmaceutical product.
© copyrights: all rights reserved
Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen
Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte prüfen Sie die Details und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.